The Blue Jays continued to aggressively shop in both the free agent and trade markets, adding what they hope are the finishing touches on a postseason contender.
Major League Signings
- Kevin Gausman, SP: Five years, $110MM
- Yusei Kikuchi, SP: Three years, $36MM
- Yimi Garcia, RP: Two years, $11MM (includes $1MM buyout of $5MM club option for 2024; option vests for $6MM if Garcia hits innings/appearance thresholds)
- Andrew Vasquez, RP: One year, $800K
- 2022 spending: $42.8MM
- Total spending: $157.8MM
Trades & Claims
- Acquired 3B Matt Chapman from the Athletics for IF Kevin Smith, SP Gunnar Hoglund, SP Zach Logue, and RP Kirby Snead
- Acquired OF Raimel Tapia and IF Adrian Pinto from the Rockies for OF Randal Grichuk and cash ($9,716,333)
- Acquired OF Bradley Zimmer from the Guardians for RP Anthony Castro
- Acquired C Zack Collins from the White Sox for C Reese McGuire
- Claimed RP Shaun Anderson off waivers from the Padres
Notable Minor League Signings
- David Phelps (contract selected, $1.75MM guarantee), Tyler Heineman (selected), Gosuke Katoh (selected), Dexter Fowler, Mallex Smith, Joshua Fuentes, Joe Biagini, Jose De Leon, Casey Lawrence, Eric Stamets, Nathan Lukes
Extensions
- Jose Berrios, SP: Seven years, $131MM (Berrios can opt out after the 2026 season)
- Matt Chapman, 3B: Two years, $25MM (avoiding arbitration)
Notable Losses
- Marcus Semien, Robbie Ray, Steven Matz, Corey Dickerson, Joakim Soria (retirement), Breyvic Valera, Kirby Yates, Grichuk, Hoglund, Smith, Logue, Snead
The Blue Jays headed into the offseason with three of their biggest 2021 contributors entering the free agent market, and the entire trio signed with new teams before the lockout. Marcus Semien’s seven-year, $175MM deal with the Rangers was the priciest of the bunch, with Robbie Ray also landing five years and $115MM from the Mariners, and Steven Matz receiving a healthy four-year, $44MM payday from the Cardinals. There wasn’t much expectation that the Blue Jays would re-sign all three of these players, though it perhaps counted as a bit of a surprise that none of the three ended up returning.
Still, given how it was another “in on everyone” offseason for the Jays’ front office, it was clear the team had plenty of contingency plans in the event that all three free agents did indeed leave town. Since Semien and Ray rejected qualifying offers, the Jays also netted two extra compensatory draft picks, so Toronto will now be picking four times within the first 78 selections of July’s amateur draft.
The Jays dabbled in the pool of qualifying offer free agents themselves, as Toronto was linked to the likes of Freddie Freeman, Corey Seager, Justin Verlander, Eduardo Rodriguez, Chris Taylor, and Michael Conforto. As for non-QO free agents, Kyle Schwarber and Seiya Suzuki were two of the more prominent names known to be of interest to Canada’s team.
Amidst all of these targets, the Blue Jays’ biggest pre-lockout strike was a player who had been on the club’s radar for years. GM Ross Atkins had tried to sign Kevin Gausman in each of the past two offseasons, and the third time was the charm — at the cost of a five-year, $110MM contract. Gausman would’ve obviously come much cheaper two winters ago when he was coming off a tough 2019 season with the Braves and Reds, but after two outstanding seasons with the Giants, he’d put himself into the top tier of available arms. At least through four starts of the 2022 season, Gausman has continued to pitch like an ace, showing early signs that his good form can carry over to the tough AL East.
The Blue Jays also moved to lock up an in-house member of their starting staff, extending Jose Berrios for a seven-year, $131MM pact. The deal kept Berrios off the 2022-23 free agent market, and reinforced the belief that the Jays already showed in the right-hander by giving up prospects Austin Martin and Simeon Woods Richardson to acquire Berrios from the Twins at last summer’s trade deadline.
Berrios and manager Charlie Montoyo were the only extensions of note during the Toronto offseason, apart from the club’s two-year pact with trade acquisition Matt Chapman over his two remaining arbitration years. It seems as though the Blue Jays have yet to really dive into serious extension talks with either Vladimir Guerrero Jr. or Bo Bichette, but with both players controlled through 2025, the clock isn’t ticking too loudly for a long-term deal to be immediately reached.
Once the lockout was over, the Jays added another piece of the rotation puzzle by signing Yusei Kikuchi to a three-year, $36MM deal. It was an intriguing bet on a pitcher who was quite inconsistent over his first three Major League seasons, with the 2021 campaign acting as a microcosm of Kikuchi’s duality. An outstanding first half earned the southpaw a trip to the All-Star Game, yet he struggled so much in the second half that the Mariners (who were fighting for a wild card berth) skipped him in the rotation in the last week of the season.
In essence, the Jays are hoping that pitching coach Pete Walker can straighten out Kikuchi in the same manner that Ray and Matz were revived after coming to Toronto. As a bit of a hedge, the front-loaded nature of Kikuchi’s contract (he’ll earn $16MM in 2022) could make him a bit easier to eventually unload if he does continue to struggle.
Turning to the bullpen, the Jays made both a notable investment and a lower-cost signing that they hope will pay dividends. Yimi Garcia was added for $11MM to bring some more experience to the Blue Jays’ fleet of setup men, while David Phelps offers some of that same veteran stature at the lower price of $1.75MM (after Toronto selected Phelps’ minor league contract). 2021 was another injury-marred season for Phelps, who missed all of 2018 recovering from Tommy John surgery and was then limited to 65 1/3 innings over the 2019-21 seasons.
With some holes on the pitching staff filled, the question of how to replace Semien stood out as perhaps the biggest issue facing the Blue Jays after the lockout. The Santiago Espinal/Cavan Biggio tandem was penciled in for either second or third base, depending on which infield position Toronto chose to address with a new addition.
That new add came at the hot corner, as the Blue Jays took advantage of the Athletics’ fire sale by picking up Matt Chapman for a package of four younger players. Gunnar Hoglund was one of the top prospects in Toronto’s farm system, but since the 2021 first-rounder is coming off Tommy John surgery, the Jays might have considered him more valuable as a trade chip than as a building block. The other three players dealt (Kevin Smith, Zach Logue, Kirby Snead) are controllable and more ready to play in the majors, with Smith standing out as an interesting pickup for Oakland considering his own high ceiling and prospect status. Surely the bonus of those two QO compensation picks played into the Jays’ thinking in trading from their prospect depth, especially considering the MVP-candidate production Chapman displayed in 2018-19.
At his best, Chapman is one of the game’s best all-around players, combining Platinum Glove-winning defense with above-average offense. That bat hasn’t been as dangerous in 2020-21, however, as Chapman has seemingly struggled due to a hip injury that required surgery in September 2020. In the small sample size of the 2022 season’s first 18 games, Chapman isn’t walking much or generating huge power. He’s cut down on his strikeouts a bit, however, and his hard-contact rate and exit velocity are back in line with his pre-injury numbers.
Considering how many other notable position players the Jays were reportedly exploring, it will make some interesting “what if” debates if Chapman replicates his 2021 struggles. For instance, Jose Ramirez was rumored to be a Jays trade target for years, and Toronto was never quite able to put together an offer that swayed the Guardians into dealing the All-Star. (As it turned out, Ramirez stayed put entirely by signing an extension that stands as the largest contract in Cleveland’s franchise history.)
Adding a switch-hitter like Ramirez, or a left-handed bat like Seager, Freeman, or Schwarber would’ve made for a smoother fit at least from a lineup balance standpoint, considering how the Jays’ ideal starting lineup is almost entirely right-handed. To address this issue, Toronto focused on adding left-handed hitters to its bench, trading for Raimel Tapia, Bradley Zimmer, and Zack Collins in a trio of swaps.
The Tapia deal was the highest-profile of the bunch, as he and infield prospect Adrian Pinto were acquired from the Rockies for Randal Grichuk and a little over half of the $18.66MM owed to Grichuk through the 2023 season. Reports surfaced in December that the Blue Jays had also looked into moving Grichuk to the Brewers for Jackie Bradley Jr., another left-handed hitter (though known more for his standout defense). Grichuk is off to a scorching (if likely BABIP-aided) start in Colorado, yet after three lackluster seasons in Toronto, the outfielder began to look like an expensive spare part.
If Grichuk does benefit from a change of scenery, the Jays are hoping the same is true for Tapia, Zimmer, and Collins, who were all well-regarded prospects who never broke out with their original teams. As it has turned out, all three players have seen more action than expected in the early going, due to oblique injuries for both Teoscar Hernandez and Danny Jansen. Collins has in particular blossomed with this extra playing time, as he has even received some DH at-bats as the Blue Jays have endeavored to keep him in the lineup.
Losing Hernandez, Jansen, Hyun Jin Ryu, and Nate Pearson to the injured list hasn’t done much to slow the Blue Jays down in April, and the team is thus far living up to the high expectations shared by the players, the front office, and the Toronto fanbase. Given how the Jays clearly have their eyes on a championship, it seems certain that more upgrades are still to come prior to the trade deadline, and the rotation already stands out as a potential area of need in light of Ryu’s health issues and rough outings on the mound.
In the same way that Chapman will be (fairly or unfairly) compared to other star players the Jays “could have” landed instead, Gausman and Kikuchi will be competing in some sense against Verlander, E-Rod, and such pitchers the Blue Jays reportedly discussed in trade talks, such as the Reds’ Tyler Mahle or Luis Castillo. However, Toronto is hoping that Ross Stripling can fill in for Ryu, and that Pearson can eventually get healthy and provide some extra rotation depth — at least until more reinforcements can be added at the trade deadline.
The team’s approximate $172.3MM payroll is a franchise high, though also not too far beyond what the Blue Jays were spending as recently as 2017. While a splurge into the $200MM threshold seems unlikely, there hasn’t been any indication that the Jays have hit the top end of their budget, so some payroll space will quite probably be available for more in-season additions.
The good news for the Jays is that even as presently configured, the roster looks like a contender. While nothing can really be ruled out for a team in win-now mode, much of the heavy lifting has already been done over the offseason to reinforce an already strong core.
DocBB
Biggest move for the Blue Jays was done by Justin Trudeau by not allowing vaccinated opponents into Canada. This is a huge advantage for the Blue Jays that no one is talking about.
Dustyslambchops23
Only because most people are smart enough to realize that the US has the same rules and the only reason it’s not a disadvantage for the Jays is that their team is all vaccinated.
DocBB
That’s not true. It is only for non-US citizens which is a minority MLB players. US citizens are not required to be vaccinated to enter the US which accounts for almost 75% of US ball players.
Dustyslambchops23
That is not accurate. Working in a different country has a separate set of rules as it relates to their working visas, which all players US born or not, are subject to.
thebaseballfanatic
I don’t understand why some fans think this is the case. Can’t we all do a little research before posting about these sorts of things?
The mandate is a humongous disadvantage for the Blue Jays. If any player on their roster was unvaccinated, they wouldn’t be able to play half of the team’s games (the ones taking place in Toronto). The front office was prevented from signing or trading for a single player that was unvaccinated throughout the entire offseason due to this. The Blue Jays aren’t “advantaged” by this at all, they were FORCED to take all the necessary measures (having a fully vaccinated club) to prevent a player on their roster from missing half the season due to the protocol. Good gracious me…
Sideline Redwine
I don’t know how this has anything to do with “research”–you each make an argument, and each provided reasons for your claim. You mean research the same things you did to have the same conclusion? If an AL East’s two best players are not vaccinated, for example, the Jays certainly have an advantage. With regard to the offseason, if they did go after anyone who was not vaccinated, chances are this discussion would be had…and the player would consider whether signing with Toronto was worth the vax. “Force” is what this is all about–Canada is not exactly about free choice, as both NBA and MLB players can attest, the Jays understand this. How about this: you each have a theory, and each can be supported via various claims. The original post is not ignorant…simply different…which, then again, seems to be a problem for many these days.
thebaseballfanatic
I understand your point, considering a matter of opinion the original post is perfectly reasonable.
The only points on which I disagreed with the original poster were suggesting the enforcing of the mandate was in itself a huge advantage for a singular team, and only referring to “opponents” in their argument rather than considering the universal effect of implementing that policy.
That can indeed be attributed to an ideology/theory rather than fact, as you suggest above.
DocBB
Blue Jays can easily just get rid of those players though or not sign them. So yes that is a disadvantage to some degree but once your roster is set your advantage is larger as 100% f your team is vaccinated where as the average MLB team has about 80-90% vaccination rate. Let’s not conflate the 2 issues as they are separate issues.
Dustyslambchops23
Doc, that is not a great argument.
If Vlad or Springer had said they were not vaccinated how could the jays ‘easily’ get rid of those players? While simultaneously improving their team.
Or better yet, what if Gausman was not vaccinated, what other SP would the jays have been able to add to the top of their rotation?
You deem it an advantage for the jays because of the players vax status only, not the rules around them.
smuzqwpdmx
Forced to have a club which will probably lose the fewest player games to COVID. Keeping players healthier and on the field more is an advantage.
No player is stupid enough to sacrifice millions of dollars to refuse to be vaccinated. They’re not paid when they can’t cross the border. If that’s missing 3 days of pay, some will do it… if it’s missing 81 days of pay, nobody is doing that.
Note the Red Sox had to convince Trevor Story to get vaccinated so he could come to Toronto, otherwise they wouldn’t have signed him.
C-Daddy
Let’s also not overlook the fact that they played more than half of their “home”games in minor league stadiums last year where the crowds largely supported the opposing team, and ended up missing the playoffs by a single game. They were hugely disadvantaged last year so any “advantage” they have this year (spoiler alert: they don’t have an advantage) can be seen as things evening out.
Starvenger
Yes, he’s clearly trying to make up for the previous two seasons where the Jays were effectively not allowed to play in Toronto. /s
goalieguy41
So not allowing “vaccinated players” into Canada. So no teams are allowed to come to Canada?
bucsfan0004
The Jays made some smart moves in the offseason to improve their already super-talented team, and instead of commenting on that, you dimwits hijack this post into Covid BS.
Dustyslambchops23
I’m guessing the ‘can’t believe they picked Gausman over Ray’ crowd is going to be pretty quiet in this thread
The offseason was important but it was also the moves at last deadline that really improved the team. Acquiring cimber, Berrios and Richards all with atleast one more year of control, lifted the floor for this year before the offseason even started.
Also impressive is that the jays have no impactful players on expiring contracts this year.
osonvs
Gausman’s solid start to the season coupled with Ray losing a couple MPH off his fastball so stand out as eye openers so far but I wouldn’t judge the comparison too quickly yet. There’s still plenty of baseball to be played and things will even themselves out as the season progresses. Both players will have their ups and downs.
flamingbagofpoop
He didn’t say they were wrong or would be quiet forever, just that they would be in this thread…since to this point, it seems like the correct decision.
Old York
100+ win team this year.
flamingbagofpoop
They have the talent for it, but I wouldn’t be surprised if they fall a little short just due to the competition (not counting the O’s) that they face in their division.
Asfan0780
Still early, but so far chapman trade not looking that good for either team. Although jays didn’t give up any of their top rated prospects
Dustyslambchops23
He’s on pace for the same 4 WAR season he had last year once his BB% comes up. That’s the player the jays acquired, anything beyond that is a bonus
C-Daddy
Chapman has been exactly as advertised- elite defense and on pace for 30+ homers.
Ted
It doesn’t help that his dWAR is currently negative for the year, but small sample sizes of defensive statistics are silly.
C-Daddy
I have watched almost every game this year and he has been great – it’s definitely a small sample size issue.
Dustyslambchops23
He’s so damn effortless and good. I haven’t seen arm strength and accuracy like that from a third baseman since Rolen
HBan22
They made the right move in signing Gausman over Ray in my opinion. Solid offseason overall, wasn’t a huge fan of the Kikuchi signing for them though.
C-Daddy
Kikuchi definitely has the potential to be good if they can improve his pitch selection, though that’s easier said than done.
Best Screenname Ever
They were having internet hysterics when their FO signed Gausman rather than Ray. Remember? Their FO was stupid and cheap because Ray signed for more.
C-Daddy
Yeah, the casual fans were saying that. Those who knew better acknowledged that it was a reasonable signing.
Mario93
Jays have probably one of the toughest schedules, definitely is tougher then the Yankees to start out the season. Going against the Yankees, Astros, Red Sox, while the Yankees play 8 games against the orioles, play Cleveland. Major League Baseball tried to make sure the Yankees are on top of the division early, thank god the Jays keep fighting to stay atop.
C-Daddy
The Jays get to play Baltimore 12 times in August/September/October, so that’ll benefit them down the stretch. I think playing the good teams early in the year is preferable as a lot of hitters haven’t found their timing yet etc.
Edp007
Ray is unvaccinated, couldn’t cross that bridge. Non starter.
Yankee Clipper
Considering what the Jays lost, the needs they had to fill, & the moves they were able to make, this had to be one of the best offseasons out of the 30 clubs. Each position of need they filled with equal or better talent, or, in Semien’s case, they understood the maturity of their young core would make up for the production lost with Semien leaving.
Outstanding job for their FO. And, if you look at letting Ray go, with his (early) downgrade in performance in favor of pivoting to Gausman, whose performance has maintained, it’s brilliant.
Chapman is the best defensive 3B in the American League (my opinion), and has solid pop – awesome complement to Bichette on the left side; And Grichuk is another pesky, Pillar-type grinder that will no doubt hit clutch HRs against the Yankees late in the year when we need the wins…
flamingbagofpoop
So you are happy they got rid of Grichuk? Or did you mean Tapia
Yankee Clipper
Tapia… is the same, but yes, Grichuk is a pain too. However, I did mean to write Tapia. He has some sneaky pop.
That’s not even including the Barrios trade, which I think was well worth it. Barrios is an excellent pitcher to have on staff. Overall, they’re just an excellent team & I think they’re the favorites for the division out of the gate.
Starscream
When you look at a 12-7 team (particularly one that has played more than 50% of those games vs .500+ opponents), it’s easy to think they must have pulled the right strings in the winter market.
That’s the read in a vacuum, but when you look at this team in context, the true impressive nature of Toronto’s offseason shines through.
This is a team that plays in a division where 91 wins netted them 4th (!) place … ahead of only the Orioles.
Now take that 4th place finish and subtract the #3 MVP finisher (who also happened to set a HR record for second basemen).
Next, subtract the reigning Cy Young winner, and another starter who went 14-7 with a WAR over 2.
Suddenly, this sounds like the beginning of the end.
Instead, the FO made a series of acquisitions that has people debating not how much they will regress, but whether they are actually the division favorites for 2022.
Without regard to in-season accomplishments, or where the Jays ultimately end up, record-wise, to absorb such significant losses, and still be pegged as a team that has improved on paper has to make this one of the most skillfully navigated offseasons by any team, ever.
jason 54
Losing Palacios and Castro for Zimmer stings me. Especially since Palacios would be getting playing time rn. And Zimmer has 2,1 or zero hits depending on how you look at it.